Table 2

Retained clinical conditions and QOF indicators (care bundles and components)
Secondary prevention of Coronary Heart Disease (CHD)
The percentage of patients with coronary heart disease:
CHD6 …in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less
CHD8 …whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less
CHD9 …with a record in the previous 15 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
CHD10 …who are currently treated with a beta blocker (unless a contraindication or side-effects are recorded)
CHD11 …a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor or Angiotensin II antagonist
CHD12 …who have a record of influenza immunisation in the preceding 1 September to 31 March
Chronic kidney disease (CKD)
The percentage of patients on the CKD register:
CKD3 …whom the last blood pressure reading, measured in the previous 15 months, is 140/85 or less
CKD5 …with hypertension and proteinuria who are treated with an angiotensin converting enzyme inhibitor (ACE – I) or angiotensin receptor blocker (ARB) (unless a contraindication or side effects are recorded)
CKD6 …whose notes have a record of a urine albumin: creatinine ratio (or protein: creatinine ratio) test in the previous 15 months
Diabetes mellitus (DM)
The percentage of patients with diabetes:
DM2 …whose notes record BMI in the previous 15 months
DM24 …in whom the last HbA1c is 8 or less (or equivalent test/reference range depending on local laboratory) in the previous 15 months
DM9 …with a record of the presence or absence of peripheral pulses in the previous 15 months
DM10 …with a record of neuropathy testing in the previous 15 months
DM12 …in whom the last blood pressure is 145/85 or less
DM15 …with a diagnosis of proteinuria or micro-albuminuria who are treated with ACE inhibitors (or A2 antagonists)
DM17 …whose last measured total cholesterol within the previous 15 months is 5 mmol/l or less
DM18 …who have had influenza immunisation in the preceding 1 September to 31 March
Chronic obstructive pulmonary disease (COPD)
The percentage of patients with COPD:
COPD10 …with a record of FeV1 in the previous 15 months
COPD13 …who have had a review, undertaken by a healthcare professional, including an assessment of breathlessness using the MRC dyspnoea score in the preceding 15 months
COPD8 …who have had influenza immunisation in the preceding 1 September to 31 March
Stroke and transient ischaemic attack (Stroke/TIA)
The percentage of patients with:
STROKE6 …a history of TIA or stroke in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less
STROKE8 …TIA or stroke whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less
STROKE12 … with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), m or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
STROKE10 …TIA or stroke who have had influenza immunisation in the preceding 1 September to 31 March

de Wet et al.

de Wet et al. BMC Health Services Research 2012 12:351   doi:10.1186/1472-6963-12-351

Open Data